Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low Dose Steroid + Mycophenolic Acid in MCNS
NCT01197040Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Oct 2009
- Primary completion
- Jul 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of mycophenolic acid in nephrosis (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Complete Remission Rate at 4 weeks. Started Oct 2009; status: completed.
02
Drugs
mycophenolic acid
03
Conditions
nephrosis
Beyond the preview
Go deeper on NCT01197040.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01197040.